Sirona Biochem Corp. and Cincinnati Children's Hospital Medical Center announced the formalization of a license agreement of Cincinnati Children's patented synthetic vernix technology. Sirona Biochem plans to create an anti-aging skin care treatment that combines their patented cell preservation glycoprotein with Cincinnati Children's technology.

Sirona will lead the development, with support from Cincinnati Children's, of the anti-aging cream incorporating the proprietary technologies of each organization. The resulting new anti-aging product will be patented with the goal of licensing the new technology to a global leader in the cosmetic and consumer packaged good marketplaces.